substance p has been researched along with imidapril in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, T; Fujiwara, H; Kashiki, Y; Takaya, T; Toshima, S; Yasuda, Y; Yoshimii, N | 1 |
| Arai, T; Fujiwara, H; Sekizawa, K; Yoshimi, N | 1 |
| Hattori, N; Kohno, N; Nakashima, T; Okimoto, M; Yanagida, J | 1 |
3 trial(s) available for substance p and imidapril
| Article | Year |
|---|---|
Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and symptomless dysphagia.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Deglutition Disorders; Female; Humans; Hypertension; Imidazoles; Imidazolidines; Losartan; Male; Pneumonia, Aspiration; Stroke; Substance P | 2000 |
Serum substance P concentrations and silent aspiration in elderly patients with stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Imidazolidines; Male; Pneumonia, Aspiration; Stroke; Substance P; Treatment Outcome | 2003 |
Nicergoline improves dysphagia by upregulating substance P in the elderly.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Deglutition; Deglutition Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Geriatric Assessment; Humans; Imidazolidines; Male; Nicergoline; Pilot Projects; Pneumonia, Aspiration; Prospective Studies; Recovery of Function; Reference Values; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Substance P; Treatment Outcome; Up-Regulation | 2011 |